Kura Oncology, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 COGT
|
Cogent Biosciences, Inc. | $9.98 | $802.20 M | -3.37 | 164 | $0 |
|
CRNX
|
Crinetics Pharmaceuticals, Inc. | $57.88 | $3.53 B | -11.86 | 290 | $4.01 M |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $15.14 | $1.12 B | -5.11 | 174 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.55 | $217.51 M | -3.7 | 57 | $0 |
 ERAS
|
Erasca, Inc. | $2.95 | $647.94 M | -2.83 | 126 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $9.36 | $243.38 M | -1.59 | 129 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
|
INZY
|
Inozyme Pharma, Inc. | $4.06 | $286.39 M | -3.43 | 59 | $0 |
 KALV
|
KalVista Pharmaceuticals, Inc. | $11.25 | $492.76 M | -3.74 | 150 | $0 |
 KNSA
|
Kiniksa Pharmaceuticals, Ltd. | $22.04 | $1.35 B | 146.62 | 297 | $270.26 M |
 LRMR
|
Larimar Therapeutics, Inc. | $7.36 | $611.84 M | -9.99 | 42 | $0 |
|
MRUS
|
Merus N.V. | $51.75 | $3.50 B | -19.38 | 172 | $43.95 M |
|
PTGX
|
Protagonist Therapeutics, Inc. | $45.96 | $2.04 B | 13.7 | 125 | $60.00 M |
 REPL
|
Replimune Group, Inc. | $12.02 | $485.18 M | -2.44 | 331 | $0 |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $19.73 | $1.66 B | -6.02 | 184 | $0 |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |
 VRDN
|
Viridian Therapeutics, Inc. | $23.31 | $776.72 M | -2.71 | 94 | $314,000 |
 ZNTL
|
Zentalis Pharmaceuticals, Inc. | $3.79 | $754.16 M | -3.26 | 124 | $0 |